These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

583 related articles for article (PubMed ID: 21983497)

  • 1. Medication adherence and subjective weight perception in patients with first-episode psychotic disorder.
    Wong MM; Chen EY; Lui SS; Tso S
    Clin Schizophr Relat Psychoses; 2011 Oct; 5(3):135-41. PubMed ID: 21983497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Weight changes and their associations with demographic and clinical characteristics in risperidone maintenance treatment for schizophrenia.
    Xiang YT; Wang CY; Ungvari GS; Kreyenbuhl JA; Chiu HF; Lai KY; Lee EH; Bo QJ; Dixon LB
    Pharmacopsychiatry; 2011 Jun; 44(4):135-41. PubMed ID: 21710403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of subjective treatment satisfaction with antipsychotics in schizophrenia patients.
    Fujikawa M; Togo T; Yoshimi A; Fujita J; Nomoto M; Kamijo A; Amagai T; Uchikado H; Katsuse O; Hosojima H; Sakura Y; Furusho R; Suda A; Yamaguchi T; Hori T; Kamada A; Kondo T; Ito M; Odawara T; Hirayasu Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):755-60. PubMed ID: 18226436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relationships between insight and medication adherence in subjects with psychosis].
    Droulout T; Liraud F; Verdoux H
    Encephale; 2003; 29(5):430-7. PubMed ID: 14615692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals.
    Day JC; Bentall RP; Roberts C; Randall F; Rogers A; Cattell D; Healy D; Rae P; Power C
    Arch Gen Psychiatry; 2005 Jul; 62(7):717-24. PubMed ID: 15997012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How do socio-demographic and clinical factors interact with adherence attitude profiles in schizophrenia? A cluster-analytical approach.
    Beck EM; Cavelti M; Wirtz M; Kossowsky J; Vauth R
    Psychiatry Res; 2011 May; 187(1-2):55-61. PubMed ID: 21074860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment adherence in schizophrenia and schizoaffective disorder.
    Goff DC; Hill M; Freudenreich O
    J Clin Psychiatry; 2011 Apr; 72(4):e13. PubMed ID: 21527119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
    Bret P; Bret MC; Queuille E
    Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for medication non-adherence in patients with first episode schizophrenia and related disorders; a prospective five year follow-up.
    de Haan L; van Amelsvoort T; Dingemans P; Linszen D
    Pharmacopsychiatry; 2007 Nov; 40(6):264-8. PubMed ID: 18030650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Body weight perception and methods of weight reduction used by patients with first-episode psychotic disorders in Hong Kong.
    Wong MM
    East Asian Arch Psychiatry; 2010 Dec; 20(4):169-73. PubMed ID: 22348925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maintenance treatment with long-acting injectable risperidone in first-episode schizophrenia: a randomized effectiveness study.
    Weiden PJ; Schooler NR; Weedon JC; Elmouchtari A; Sunakawa-McMillan A
    J Clin Psychiatry; 2012 Sep; 73(9):1224-33. PubMed ID: 22938760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extent of weight gain in patients with first-episode psychotic disorders after one year of antipsychotic treatment in Hong Kong.
    Wong MM
    East Asian Arch Psychiatry; 2010 Jun; 20(2):57-61. PubMed ID: 22351810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationships between insight and medication adherence in outpatients with schizophrenia and bipolar disorder: prospective study.
    Yen CF; Chen CS; Ko CH; Yeh ML; Yang SJ; Yen JY; Huang CF; Wu CC
    Psychiatry Clin Neurosci; 2005 Aug; 59(4):403-9. PubMed ID: 16048445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a 10-week weight control program on obese patients with schizophrenia or schizoaffective disorder: a 12-month follow up.
    Chen CK; Chen YC; Huang YS
    Psychiatry Clin Neurosci; 2009 Feb; 63(1):17-22. PubMed ID: 19067997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of patient and clinician perspectives in the assessment of antipsychotic medication adherence.
    Barbui C; Kikkert M; Mazzi MA; Becker T; Bindman J; Schene A; Nosè M; Helm H; Thornicroft G; Tansella M
    Psychopathology; 2009; 42(5):311-7. PubMed ID: 19672133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subjective side effects of antipsychotics and medication adherence in people with schizophrenia.
    McCann TV; Clark E; Lu S
    J Adv Nurs; 2009 Mar; 65(3):534-43. PubMed ID: 19222651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of antipsychotic side effects on attitudes towards medication in people with schizophrenia and related disorders.
    Chiang YL; Klainin-Yobas P; Ignacio J; Chng CM
    J Clin Nurs; 2011 Aug; 20(15-16):2172-82. PubMed ID: 21539628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized controlled trial of long-acting injectable risperidone vs continuation on oral atypical antipsychotics for first-episode schizophrenia patients: initial adherence outcome.
    Weiden PJ; Schooler NR; Weedon JC; Elmouchtari A; Sunakawa A; Goldfinger SM
    J Clin Psychiatry; 2009 Oct; 70(10):1397-406. PubMed ID: 19906343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence to antipsychotic drug treatment in early-episode schizophrenia: a six-month naturalistic follow-up study.
    Baloush-Kleinman V; Levine SZ; Roe D; Shnitt D; Weizman A; Poyurovsky M
    Schizophr Res; 2011 Aug; 130(1-3):176-81. PubMed ID: 21636254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.